Impact of Ectoenzymes on P2 and P1 Receptor Signaling

Advances in Pharmacology

Volumn 61, Issue , 2011, Pages 263-299

  Kukulski, Filip ^a,b   Lévesque, Sébastien A ^a,b   Sévigny, Jean ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Ecto 5' nucleotidase; Ectokinase; NPP; NTPDase; P1 and P2 receptors; Phosphatases

Indexed keywords

ACID PHOSPHATASE; ADENOSINE DIPHOSPHATE; ADENYLATE KINASE; CIBACRON BLUE F3GA; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; NUCLEOSIDE TRIPHOSPHATE; NUCLEOTIDE PYROPHOSPHATASE; URIDINE DIPHOSPHATE;

BOOK; CARBOXY TERMINAL SEQUENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; LEUKOCYTE; NEUROTRANSMISSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS;

EID: 79955954921     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385526-8.00009-6     Document Type: Chapter

References (196)

1. Abbracchio M.P., Burnstock G. Purinergic signalling: Pathophysiological roles. Japanese Journal of Pharmacology 1998, 78(2):113-145.
2. Abbracchio M.P., Burnstock G., Boeynaems J.M., et al. International Union of Pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy. Pharmacological Reviews 2006, 58(3):281-341.
3. Abbracchio M.P., Burnstock G., Verkhratsky A., et al. Purinergic signalling in the nervous system: An overview. Trends in Neurosciences 2009, 32(1):19-29.
4. Adriouch S., Bannas P., Schwarz N., et al. ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site. The FASEB Journal 2008, 22(3):861-869.
5. Airas L., Niemela J., Salmi M., et al. Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. The Journal of Cell Biology 1997, 136(2):421-431.
6. Bahrami, F., Kukulski, F., Lecka, J., et al. P2Y11 receptor and ectoenzymes control Toll- like receptor 3-induced IL-8 production in HT-29 cells. Submitted.
7. Bar I., Guns P.J., Metallo J., et al. Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells. Molecular Pharmacology 2008, 74(3):777-784.
8. Bartel D.L., Sullivan S.L., Lavoie E.G., et al. Nucleoside triphosphate diphosphohydrolase-2 is the ecto-ATPase of type I cells in taste buds. The Journal of Comparative Neurology 2006, 497(1):1-12.
9. Becker L.V., Rosa C.S., Souza Vdo C., et al. Activities of enzymes that hydrolyze adenine nucleotides in platelets from patients with rheumatoid arthritis. Clinical Biochemistry 2010, 43(13-14):1096-1100.
10. Belcher S.M., Zsarnovszky A., Crawford P.A., et al. Immunolocalization of ecto-nucleoside triphosphate diphosphohydrolase 3 in rat brain: Implications for modulation of multiple homeostatic systems including feeding and sleep-wake behaviors. Neuroscience 2006, 137(4):1331-1346.
11. Beldi G., Banz Y., Kroemer A., et al. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice. Hepatology 2010, 51(5):1702-1711.
12. Beldi G., Wu Y., Banz Y., et al. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology 2008, 48(3):841-852.
13. Belli S.I., van Driel I.R., Goding J.W. Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1 (5'-nucleotide phosphodiesterase). European Journal of Biochemistry 1993, 217(1):421-428.
14. Ben Yebdri F., Kukulski F., Tremblay A., et al. Concomitant activation of P2Y(2) and P2Y(6) receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion. European Journal of Immunology 2009, 39(10):2885-2894.
15. Benham C.D., Tsien R.W. A novel receptor-operated Ca2+-permeable channel activated by ATP in smooth muscle. Nature 1987, 328(6127):275-278.
16. Bigonnesse F., Lévesque S.A., Kukulski F., et al. Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 2004, 43(18):5511-5519.
17. Boarder M.R., Hourani S.M. The regulation of vascular function by P2 receptors: Multiple sites and multiple receptors. Trends in Pharmacological Sciences 1998, 19(3):99-107.
18. Boissan M., Dabernat S., Peuchant E., et al. The mammalian Nm23/NDPK family: From metastasis control to cilia movement. Molecular and Cellular Biochemistry 2009, 329(1-2):51-62.
19. Bollen M., Gijsbers R., Ceulemans H., et al. Nucleotide pyrophosphatases/phosphodiesterases on the move. Critical Reviews in Biochemistry and Molecular Biology 2000, 35(6):393-432.
20. Bonan C.D., Walz R., Pereira G.S., et al. Changes in synaptosomal ectonucleotidase activities in two rat models of temporal lobe epilepsy. Epilepsy Research 2000, 39(3):229-238.
21. Boucher R.C. Airway surface dehydration in cystic fibrosis: Pathogenesis and therapy. Annual Review of Medicine 2007, 58:157-170.
22. Braun N., Brendel P., Zimmermann H. Distribution of 5'-nucleotidase in the developing mouse retina. Brain Research. Developmental Brain Research 1995, 88(1):79-86.
23. Braun N., Fengler S., Ebeling C., et al. Sequencing, functional expression and characterization of rat NTPDase6, a nucleoside diphosphatase and novel member of the ecto-nucleoside triphosphate diphosphohydrolase family. The Biochemical Journal 2000, 351(Pt 3):639-647.
24. Braun N., Sévigny J., Robson S.C., et al. Association of the ecto-ATPase NTPDase2 with glial cells of the peripheral nervous system. Glia 2004, 45(2):124-132.
25. Braun N., Zhu Y., Krieglstein J., et al. Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. The Journal of Neuroscience 1998, 18(13):4891-4900.
26. Brunschweiger A., Iqbal J., Umbach F., et al. Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: Nucleotide mimetics derived from uridine-5'-carboxamide. Journal of Medicinal Chemistry 2008, 51(15):4518-4528.
27. Buhring H.J., Seiffert M., Giesert C., et al. The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3. Blood 2001, 97(10):3303-3305.
28. Burnstock G. Purinergic mechanosensory transduction and visceral pain. Molecular Pain 2009, 5:69.
29. Canales J., Pinto R.M., Costas M.J., et al. Rat liver nucleoside diphosphosugar or diphosphoalcohol pyrophosphatases different from nucleotide pyrophosphatase or phosphodiesterase I: Substrate specificities of Mg(2+)-and/or Mn(2+)-dependent hydrolases acting on ADP-ribose. Biochimica et Biophysica Acta 1995, 1246(2):167-177.
30. Chen Y., Corriden R., Inoue Y., et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006, 314(5806):1792-1795.
31. Chen Y., Yao Y., Sumi Y., et al. Purinergic signaling: A fundamental mechanism in neutrophil activation. Science Signaling 2010, 3(125):ra45.
32. Chiavegatti T., Costa V.L., Araujo M.S., et al. Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway. British Journal of Pharmacology 2008, 153(6):1331-1340.
33. Choudhary M.I., Fatima N., Khan K.M., et al. New biscoumarin derivatives-cytotoxicity and enzyme inhibitory activities. Bioorganic & Medicinal Chemistry 2006, 14(23):8066-8072.
34. Ciana P., Fumagalli M., Trincavelli M.L., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. The EMBO Journal 2006, 25(19):4615-4627.
35. Cicko S., Lucattelli M., Muller T., et al. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. Journal of Immunology 2010, 185(1):688-697.
36. Colgan S.P., Eltzschig H.K., Eckle T., et al. Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signalling 2006, 2(2):351-360.
37. Conde S.V., Monteiro E.C. Hypoxia induces adenosine release from the rat carotid body. Journal of Neurochemistry 2004, 89(5):1148-1156.
38. Corriden R., Chen Y., Inoue Y., et al. Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. The Journal of Biological Chemistry 2008, 283(42):28480-28486.
39. Crack B.E., Pollard C.E., Beukers M.W., et al. Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. British Journal of Pharmacology 1995, 114(2):475-481.
40. Di Virgilio F., Ceruti S., Bramanti P., et al. Purinergic signalling in inflammation of the central nervous system. Trends in Neurosciences 2009, 32(2):79-87.
41. Duarte-Araujo M., Nascimento C., Timoteo M.A., et al. Relative contribution of ecto-ATPase and ecto-ATPDase pathways to the biphasic effect of ATP on acetylcholine release from myenteric motoneurons. British Journal of Pharmacology 2009, 156(3):519-533.
42. Dzeja P., Terzic A. Adenylate kinase and AMP signaling networks: Metabolic monitoring, signal communication and body energy sensing. International Journal of Molecular Sciences 2009, 10(4):1729-1772.
43. Eckle T., Fullbier L., Wehrmann M., et al. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. Journal of Immunology 2007, 178(12):8127-8137.
44. Eckle T., Kohler D., Lehmann R., et al. Hypoxia-inducible factor-1 is central to cardioprotection: A new paradigm for ischemic preconditioning. Circulation 2008, 118(2):166-175.
45. Eckle T., Krahn T., Grenz A., et al. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation 2007, 115(12):1581-1590.
46. Eliahu S., Lecka J., Reiser G., et al. Diadenosine-5'-5(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors. Journal of Medicinal Chemistry 2010, 53(24):8485-8497.
47. Eltzschig H.K., Eckle T., Mager A., et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circulation Research 2006, 99(10):1100-1108.
48. Eltzschig H.K., Ibla J.C., Furuta G.T., et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: Role of ectonucleotidases and adenosine A2B receptors. The Journal of Experimental Medicine 2003, 198(5):783-796.
49. Eltzschig H.K., Kohler D., Eckle T., et al. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 2009, 113(1):224-232.
50. Eltzschig H.K., Macmanus C.F., Colgan S.P. Neutrophils as sources of extracellular nucleotides: Functional consequences at the vascular interface. Trends in Cardiovascular Medicine 2008, 18(3):103-107.
51. Eltzschig H.K., Thompson L.F., Karhausen J., et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: Coordination by extracellular nucleotide metabolism. Blood 2004, 104(13):3986-3992.
52. Enjyoji K., Sévigny J., Lin Y., et al. Targeted disruption of CD39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nature Medicine 1999, 5(9):1010-1017.
53. Fabre A.C., Vantourout P., Champagne E., et al. Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes. Cellular and Molecular Life Sciences 2006, 63(23):2829-2837.
54. Failer B.U., Aschrafi A., Schmalzing G., et al. Determination of native oligomeric state and substrate specificity of rat NTPDase1 and NTPDase2 after heterologous expression in Xenopus oocytes. European Journal of Biochemistry 2003, 270(8):1802-1809.
55. Faria M., Magalhaes-Cardoso T., Lafuente-de-Carvalho J.M., et al. Decreased ecto-NTPDase1/CD39 activity leads to desensitization of P2 purinoceptors regulating tonus of corpora cavernosa in impotent men with endothelial dysfunction. Nucleosides, Nucleotides & Nucleic Acids 2008, 27(6):761-768.
56. Fausther M., Lecka J., Kukulski F., et al. Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8. American Journal of Physiology. Gastrointestinal and Liver Physiology 2007, 292(3):G785-G795.
57. Fausther M., Pelletier J., Ribeiro C.M., et al. Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3. American Journal of Physiology. Lung Cellular and Molecular Physiology 2010, 298(6):L804-L818.
58. Fontella F.U., Bruno A.N., Balk R.S., et al. Repeated stress effects on nociception and on ectonucleotidase activities in spinal cord synaptosomes of female rats. Physiology & Behavior 2005, 85(2):213-219.
59. Franke H., Krugel U., Illes P. P2 receptors and neuronal injury. Pflugers Archiv: European Journal of Physiology 2006, 452(5):622-644.
60. Fredholm B.B., Irenius E., Kull B., et al. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochemical Pharmacology 2001, 61(4):443-448.
61. Friedman D.J., Kunzli B.M., Yi A.R., et al. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(39):16788-16793.
62. Friedman D.J., Talbert M.E., Bowden D.W., et al. Functional ENTPD1 Polymorphisms in African-Americans with Diabetes and End-Stage Renal Disease. Diabetes 2008, 58(4):999-1006.
63. Gendron F.P., Halbfinger E., Fischer B., et al. Novel inhibitors of nucleoside triphosphate diphosphohydrolases: Chemical synthesis and biochemical and pharmacological characterizations. Journal of Medicinal Chemistry 2000, 43(11):2239-2247.
64. Gijsbers R., Ceulemans H., Stalmans W., et al. Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases. The Journal of Biological Chemistry 2001, 276(2):1361-1368.
65. Goding J.W., Grobben B., Slegers H. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochimica et Biophysica Acta 2003, 1638(1):1-19.
66. Goding J.W., Terkeltaub R., Maurice M., et al. Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: Structure and function of the PC-1 family. Immunological Reviews 1998, 161:11-26.
67. Gomez G., Sitkovsky M.V. Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 2003, 102(13):4472-4478.
68. Grenz A., Zhang H., Hermes M., et al. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. The FASEB Journal 2007, 21(11):2863-2873.
69. Grobben B., Anciaux K., Roymans D., et al. An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. Journal of Neurochemistry 1999, 72(2):826-834.
70. Grunewald J.K., Ridley A.J. CD73 represses pro-inflammatory responses in human endothelial cells. Journal of Inflammation (London) 2010, 7(1):10.
71. Halbfinger E., Gorochesky K., Lévesque S.A., et al. Photoaffinity labeling on magnetic microspheres (PALMm) methodology for topographic mapping: Preparation of PALMm reagents and demonstration of biochemical relevance. Organic & Biomolecular Chemistry 2003, 1(16):2821-2832.
72. Harmey D., Hessle L., Narisawa S., et al. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp 1, and ank: An integrated model of the pathogenesis of mineralization disorders. The American Journal of Pathology 2004, 164(4):1199-1209.
73. Hart M.L., Gorzolla I.C., Schittenhelm J., et al. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. Journal of Immunology 2010, 184(7):4017-4024.
74. Hasko G., Linden J., Cronstein B., et al. Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases. Nature Reviews. Drug Discovery 2008, 7(9):759-770.
75. Hauswirth A.W., Sonneck K., Florian S., et al. Interleukin-3 promotes the expression of E-NPP3/CD203C on human blood basophils in healthy subjects and in patients with birch pollen allergy. International Journal of Immunopathology and Pharmacology 2007, 20(2):267-278.
76. Hayman A.R. Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity 2008, 41(3):218-223.
77. Heilbronn A., Zimmermann H. 5'-nucleotidase activates and an inhibitory antibody prevents neuritic differentiation of PC12 cells. The European Journal of Neuroscience 1995, 7(6):1172-1179.
78. Henttinen T., Jalkanen S., Yegutkin G.G. Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by ecto-5'-nucleotidase/CD73-dependent mechanism. The Journal of Biological Chemistry 2003, 278(27):24888-24895.
79. Hessle L., Johnson K.A., Anderson H.C., et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(14):9445-9449.
80. Hicks-Berger C.A., Chadwick B.P., Frischauf A.M., et al. Expression and characterization of soluble and membrane-bound human nucleoside triphosphate diphosphohydrolase 6 (CD39L2). The Journal of Biological Chemistry 2000, 275(44):34041-34045.
81. Hong S., Brass A., Seman M., et al. Lipopolysaccharide, IFN-gamma, and IFN-beta induce expression of the thiol-sensitive ART2.1 ecto-ADP-ribosyltransferase in murine macrophages. Journal of Immunology 2007, 179(9):6215-6227.
82. Hong S., Brass A., Seman M., et al. Basal and inducible expression of the thiol-sensitive ART2.1 ecto-ADP-ribosyltransferase in myeloid and lymphoid leukocytes. Purinergic Signalling 2009, 5(3):369-383.
83. Hoshi K., Amizuka N., Oda K., et al. Immunolocalization of tissue non-specific alkaline phosphatase in mice. Histochemistry and Cell Biology 1997, 107(3):183-191.
84. Hosoda N., Hoshino S.I., Kanda Y., et al. Inhibition of phosphodiesterase/pyrophosphatase activity of PC-1 by its association with glycosaminoglycans. European Journal of Biochemistry 1999, 265(2):763-770.
85. Hubert S., Rissiek B., Klages K., et al. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. The Journal of Experimental Medicine 2010, 207(12):2561-2568.
86. Hyman M.C., Petrovic-Djergovic D., Mazer S.P., et al. ENTPDase (CD39) downregulates monocyte and neutrophil MAC-1 expression. Circulation 2007, 116:II_208.
87. Hyman M.C., Petrovic-Djergovic D., Visovatti S.H., et al. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. Journal of Clinical Investigation 2009, 119(5):1136-1149.
88. Idzko M., Hammad H., van Nimwegen M., et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nature Medicine 2007, 13(8):913-919.
89. Imai M., Goepfert C., Kaczmarek E., et al. CD39 modulates IL-1 release from activated endothelial cells. Biochemical and Biophysical Research Communications 2000, 270(1):272-278.
90. Inoue Y., Chen Y., Hirsh M.I., et al. A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis. Shock 2008, 30(2):173-177.
91. Iqbal J., Vollmayer P., Braun N., et al. A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction. Purinergic Signalling 2005, 1(4):349-358.
92. Jackson E.K., Ren J., Zacharia L.C., et al. Characterization of renal ecto-phosphodiesterase. The Journal of Pharmacology and Experimental Therapeutics 2007, 321(2):810-815.
93. Jacobson K.A., Gao Z.G. Adenosine receptors as therapeutic targets. Nature Reviews. Drug Discovery 2006, 5(3):247-264.
94. Jansen S., Stefan C., Creemers J.W., et al. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. Journal of Cell Science 2005, 118(Pt 14):3081-3089.
95. Jhandier M.N., Kruglov E.A., Lavoie E.G., et al. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. The Journal of Biological Chemistry 2005, 280(24):22986-22992.
96. Jin X., Shepherd R.K., Duling B.R., et al. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. Journal of Clinical Investigation 1997, 100(11):2849-2857.
97. Joseph S.M., Pifer M.A., Przybylski R.J., et al. Methylene ATP analogs as modulators of extracellular ATP metabolism and accumulation. British Journal of Pharmacology 2004, 142(6):1002-1014.
98. Kaczmarek E., Koziak K., Sévigny J., et al. Identification and characterization of CD39/vascular ATP diphosphohydrolase. The Journal of Biological Chemistry 1996, 271(51):33116-33122.
99. Kansas G.S., Wood G.S., Tedder T.F. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J Immunol 1991, 146(7):2235-2244.
100. Kauffenstein G., Drouin A., Thorin-Trescases N., et al. NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovascular Research 2010, 85(1):204-213.
101. Kauffenstein G., Furstenau C.R., D'Orleans-Juste P., et al. The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation. British Journal of Pharmacology 2010, 159(3):576-585.
102. Kaunitz J.D., Yamaguchi D.T. TNAP, TrAP, ecto-purinergic signaling, and bone remodeling. Journal of Cellular Biochemistry 2008, 105(3):655-662.
103. Kehlen A., Lauterbach R., Santos A.N., et al. IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clinical and Experimental Immunology 2001, 123(1):147-154.
104. Khan K.M., Fatima N., Rasheed M., et al. 1,3,4-Oxadiazole-2(3H)-thione and its analogues: A new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors. Bioorganic & Medicinal Chemistry 2009, 17(22):7816-7822.
105. Kittel A., Garrido M., Varga G. Localization of NTPDase1/CD39 in normal and transformed human pancreas. The Journal of Histochemistry and Cytochemistry 2002, 50(4):549-556.
106. Kittel A., Pelletier J., Bigonnesse F., et al. Localization of nucleoside triphosphate diphosphohydrolase-1 (NTPDase1) and NTPDase2 in pancreas and salivary gland. The Journal of Histochemistry and Cytochemistry 2004, 52(7):861-871.
107. Kobayashi T., Okada T., Garcia del Saz E., et al. Internalization of ecto-ATPase activity in human neutrophils upon stimulation with phorbol ester or formyl peptide. Histochemistry and Cell Biology 1997, 107(5):353-363.
108. Kukulski, F., Bahrami, F., Ben Yebdri, F., et al. The ectonucleotidase NTPDase1 controls IL-8 production by human neutrophils. Submitted.
109. Kukulski F., Ben Yebdri F., Bahrami F., et al. Endothelial P2Y2 receptor regulates LPS-induced neutrophil transendothelial migration in vitro. Molecular Immunology 2010, 47(5):991-999.
110. Kukulski F., Ben Yebdri F., Lecka J., et al. Extracellular ATP and P2 receptors are required for IL-8 to induce neutrophil migration. Cytokine 2009, 46(2):166-170.
111. Kukulski F., Ben Yebdri F., Lefebvre J., et al. Extracellular nucleotides mediate LPS-induced neutrophil migration in vitro and in vivo. Journal of Leukocyte Biology 2007, 81(5):1269-1275.
112. Kukulski F., Komoszynski M. Purification and characterization of NTPDase1 (ecto-apyrase) and NTPDase2 (ecto-ATPase) from porcine brain cortex synaptosomes. European Journal of Biochemistry 2003, 270(16):3447-3454.
113. Kukulski F., Lévesque S.A., Lavoie E.G., et al. Comparative hydrolysis of P2 receptor agonists by NTPDases 1,2,3 and 8. Purinergic Signalling 2005, 1(2):193-204.
114. Langer D., Ikehara Y., Takebayashi H., et al. The ectonucleotidases alkaline phosphatase and nucleoside triphosphate diphosphohydrolase 2 are associated with subsets of progenitor cell populations in the mouse embryonic, postnatal and adult neurogenic zones. Neuroscience 2007, 150(4):863-879.
115. Lavoie E.G., Fausther M., Kauffenstein G., et al. Identification of the ectonucleotidases expressed in mouse, rat and human Langerhans islets: Potential role of NTPDase3 in insulin secretion. American Journal of Physiology. Endocrinology and Metabolism 2010, 299(4):E647-E656.
116. Lavoie E.G., Gulbransen B.D., Martin-Satué M., et al. Ectonucleotidase in mouse digestive system. Focus on NTPDase3 localization. American Journal of Physiology. Gastrointestinal and Liver Physiology 2011, in press.
117. Lecka J., Bloch-Boguslawska E., Molski S., et al. Extracellular purine metabolism in blood vessels (Part II): Activity of ecto-enzymes in blood vessels of patients with abdominal aortic aneurysm. Clinical and Applied Thrombosis/Hemostasis 2010, 16(6):650-657.
118. Lecka J., Rana M.S., Sévigny J. Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation. British Journal of Pharmacology 2010, 161(5):1150-1160.
119. Lévesque S.A., Kukulski F., Enjyoji K., et al. NTPDase1 governs P2X(7)-dependent functions in murine macrophages. European Journal of Immunology 2010, 40(5):1473-1485.
120. Lévesque S.A., Lavoie E.G., Lecka J., et al. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. British Journal of Pharmacology 2007, 152(1):141-150.
121. Liao H., Hyman M.C., Baek A.E., et al. cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression. The Journal of Biological Chemistry 2010, 285(19):14791-14805.
122. Machida T., Heerdt P.M., Reid A.C., et al. Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis. The Journal of Pharmacology and Experimental Therapeutics 2005, 313(2):570-577.
123. Mamedova L., Capra V., Accomazzo M.R., et al. CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. Biochemical Pharmacology 2005, 71(1-2):115-125.
124. Martín-Satué M., Lavoie E.G., Fausther M., et al. High expression and activity of ecto-5'-nucleotidase/CD73 in the male murine reproductive tract. Histochemistry and Cell Biology 2010, 133(6):659-668.
125. Martín-Satué M., Lavoie E.G., Pelletier J., et al. Localization of plasma membrane bound NTPDases in the murine reproductive tract. Histochemistry and Cell Biology 2009, 131(5):615-628.
126. Meerson N.R., Delautier D., Durand-Schneider A.M., et al. Identification of B10, an alkaline phosphodiesterase of the apical plasma membrane of hepatocytes and biliary cells, in rat serum: Increased levels following bile duct ligation and during the development of cholangiocarcinoma. Hepatology 1998, 27(2):563-568.
127. Millan J.L. Alkaline phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signalling 2006, 2(2):335-341.
128. Millan J.L. Mammalian alkaline phosphatases: From biology to applications in medicine and biotechnology 2006, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
129. Mizumoto N., Kumamoto T., Robson S.C., et al. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness. Nature Medicine 2002, 8(4):358-365.
130. Moncrieffe H., Nistala K., Kamhieh Y., et al. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. Journal of Immunology 2010, 185(1):134-143.
131. Mulero J.J., Yeung G., Nelken S.T., et al. CD39-L4 is a secreted human apyrase, specific for the hydrolysis of nucleoside diphosphates. The Journal of Biological Chemistry 1999, 274(29):20064-20067.
132. Muller C.E., Iqbal J., Baqi Y., et al. Polyoxometalates-A new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorganic & Medicinal Chemistry Letters 2006, 16(23):5943-5947.
133. Munkonda M.N., Kauffenstein G., Kukulski F., et al. Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. Biochemical Pharmacology 2007, 74(10):1524-1534.
134. Munkonda M.N., Pelletier J., Ivanenkov V.V., et al. Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3: Partial characterization of the inhibitory epitope and potential applications. The FEBS Journal 2009, 276(2):479-496.
135. Nathan C. Neutrophils and immunity: Challenges and opportunities. Nature Reviews. Immunology 2006, 6(3):173-182.
136. Nauseef W.M. How human neutrophils kill and degrade microbes: An integrated view. Immunological Reviews 2007, 219:88-102.
137. Nigam P., Velu V., Kannanganat S., et al. Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. Journal of Immunology 2010, 184(4):1690-1701.
138. Ohkubo S., Kimura J., Matsuoka I. Ecto-alkaline phosphatase in NG108-15 cells: A key enzyme mediating P1 antagonist-sensitive ATP response. British Journal of Pharmacology 2000, 131(8):1667-1672.
139. Pacheco R., Martinez-Navio J.M., Lejeune M., et al. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(27):9583-9588.
140. Parkinson F.E., Xiong W., Zamzow C.R. Astrocytes and neurons: Different roles in regulating adenosine levels. Neurological Research 2005, 27(2):153-160.
141. Pelegrin P., Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. The EMBO Journal 2009, 28(14):2114-2127.
142. Petersen C.B., Nygard A.B., Viuff B., et al. Porcine ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1/CD203a): Cloning, transcription, expression, mapping, and identification of an NPP1/CD203a epitope for swine workshop cluster 9 (SWC9) monoclonal antibodies. Developmental and Comparative Immunology 2007, 31(6):618-631.
143. Picher M., Boucher R.C. Human airway ecto-adenylate kinase. A mechanism to propagate ATP signaling on airway surfaces. The Journal of Biological Chemistry 2003, 278(13):11256-11264.
144. Picher M., Burch L.H., Hirsh A.J., et al. Ecto 5'-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. The Journal of Biological Chemistry 2003, 278(15):13468-13479.
145. Pizzirani C., Ferrari D., Chiozzi P., et al. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 2007, 109(9):3856-3864.
146. Prosdocimo D.A., Douglas D.C., Romani A.M., et al. Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells. American Journal of Physiology. Cell Physiology 2009, 296(4):C828-C839.
147. Pulte E.D., Broekman M.J., Olson K.E., et al. CD39/NTPDase-1 activity and expression in normal leukocytes. Thrombosis Research 2007, 121(3):309-317.
148. Quintero I.B., Araujo C.L., Pulkka A.E., et al. Prostatic acid phosphatase is not a prostate specific target. Cancer Research 2007, 67(14):6549-6554.
149. Reutershan J., Vollmer I., Stark S., et al. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. The FASEB Journal 2009, 23(2):473-482.
150. Ricatti M.J., Alfie L.D., Lavoie E.G., et al. Immunocytochemical localization of NTPDases1 and 2 in the neural retina of mouse and zebrafish. Synapse 2009, 63(4):291-307.
151. Robson S.C., Sévigny J., Zimmermann H. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signalling 2006, 2(2):409-430.
152. Rucker B., Almeida M.E., Libermann T.A., et al. Biochemical characterization of ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP, E.C. 3.1.4.1) from rat heart left ventricle. Molecular and Cellular Biochemistry 2007, 306(1-2):247-254.
153. Say J.C., Ciuffi K., Furriel R.P., et al. Alkaline phosphatase from rat osseous plates: Purification and biochemical characterization of a soluble form. Biochimica et Biophysica Acta 1991, 1074(2):256-262.
154. Schaefer U., Machida T., Broekman M.J., et al. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors. The Journal of Pharmacology and Experimental Therapeutics 2007, 322(3):1269-1277.
155. Schicker K., Hussl S., Chandaka G.K., et al. A membrane network of receptors and enzymes for adenine nucleotides and nucleosides. Biochimica et Biophysica Acta 2009, 1793(2):325-334.
156. Seman M., Adriouch S., Scheuplein F., et al. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 2003, 19(4):571-582.
157. Sévigny J., Lévesque F.P., Grondin G., et al. Purification of the blood vessel ATP diphosphohydrolase, identification and localisation by immunological techniques. Biochimica et Biophysica Acta 1997, 1334(1):73-88.
158. Sévigny J., Robson S.C., Waelkens E., et al. Identification and characterization of a novel hepatic canalicular ATP diphosphohydrolase. The Journal of Biological Chemistry 2000, 275(8):5640-5647.
159. Sévigny J., Sundberg C., Braun N., et al. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 2002, 99(8):2801-2809.
160. Smoake J.A., McMahon K.L., Wright R.K., et al. Hormonally sensitive cyclic AMP phosphodiesterase in liver cells. An ecto-enzyme. The Journal of Biological Chemistry 1981, 256(16):8531-8535.
161. Sorensen C.E., Amstrup J., Rasmussen H.N., et al. Rat pancreas secretes particulate ecto-nucleotidase CD39. The Journal of Physiology 2003, 551(Pt 3):881-892.
162. Sowa N.A., Vadakkan K.I., Zylka M.J. Recombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A(1)-adenosine receptors to mediate antinociception. PLoS One 2009, 4(1):e4248.
163. Spanevello R.M., Mazzanti C.M., Bagatini M., et al. Activities of the enzymes that hydrolyze adenine nucleotides in platelets from multiple sclerosis patients. Journal of Neurology 2010, 257(1):24-30.
164. Spanevello R.M., Mazzanti C.M., Schmatz R., et al. The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients. Clinica Chimica Acta 2010, 411(3-4):210-214.
165. Stagg J., Divisekera U., McLaughlin N., et al. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(4):1547-1552.
166. Stefan C., Jansen S., Bollen M. Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic Signalling 2006, 2(2):361-370.
167. Sun X., Wu Y., Gao W., et al. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 2010, 139(3):1030-1040.
168. Synnestvedt K., Furuta G.T., Comerford K.M., et al. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. Journal of Clinical Investigation 2002, 110(7):993-1002.
169. Takahashi T., Old L.J., Boyse E.A. Surface alloantigens of plasma cells. The Journal of Experimental Medicine 1970, 131(6):1325-1341.
170. Torres I.L., Buffon A., Silveira P.P., et al. Effect of chronic and acute stress on ectonucleotidase activities in spinal cord. Physiology & Behavior 2002, 75(1-2):1-5.
171. van Waeg G., Van den Berghe G. Purine catabolism in polymorphonuclear neutrophils. Phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase. The Journal of Clinical Investigation 1991, 87(1):305-312.
172. Vekaria R.M., Shirley D.G., Sévigny J., et al. Immunolocalization of ectonucleotidases along the rat nephron. American Journal of Physiology-Renal Physiology 2006, 290(2):F550-F560.
173. Vollmayer P., Clair T., Goding J.W., et al. Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/phosphodiesterases. European Journal of Biochemistry 2003, 270(14):2971-2978.
174. von Kugelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacology & Therapeutics 2006, 110(3):415-432.
175. Vorhoff T., Zimmermann H., Pelletier J., et al. Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: Predicted secondary structure and relation to other members of the E-NTPDase family and actin. Purinergic Signalling 2005, 1(3):259-270.
176. Wagner J.G., Roth R.A. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacological Reviews 2000, 52(3):349-374.
177. Wall M.J., Wigmore G., Lopatar J., et al. The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition. Neuropharmacology 2008, 55(7):1251-1258.
178. Warny M., Aboudola S., Robson S.C., et al. P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. The Journal of Biological Chemistry 2001, 276(28):26051-26056.
179. Weihofen W.A., Liu J., Reutter W., et al. Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface. The Journal of Biological Chemistry 2004, 279(41):43330-43335.
180. Weissmuller T., Campbell E.L., Rosenberger P., et al. PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. Journal of Clinical Investigation 2008, 118(11):3682-3692.
181. Weissmuller T., Eltzschig H.K., Colgan S.P. Dynamic purine signaling and metabolism during neutrophil-endothelial interactions. Purinergic Signalling 2005, 1(3):229-239.
182. Wiginton D.A., Kaplan D.J., States J.C., et al. Complete sequence and structure of the gene for human adenosine deaminase. Biochemistry 1986, 25(25):8234-8244.
183. Wink M.R., Braganhol E., Tamajusuku A.S., et al. Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience 2006, 138(2):421-432.
184. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochimica et Biophysica Acta 2008, 1783(5):673-694.
185. Yegutkin G.G., Henttinen T., Samburski S.S., et al. The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells. The Biochemical Journal 2002, 367(Pt 1):121-128.
186. Yegutkin G.G., Jankowski J., Jalkanen S., et al. Dinucleotide polyphosphates contribute to purinergic signaling via inhibition of adenylate kinase activity. Bioscience Reports 2008, 28(4):189-194.
187. Yu J., Lavoie E.G., Sheung N., et al. IL-6 downregulates transcription of NTPDase2 via specific promoter elements. American Journal of Physiology. Gastrointestinal and Liver Physiology 2008, 294(3):G748-G756.
188. Zacher L.A., Carey G.B. Cyclic AMP metabolism by swine adipocyte microsomal and plasma membranes. Comparative Biochemistry and Physiology. Part B: Biochemistry & Molecular Biology 1999, 124(1):61-71.
189. Zahn P.K., Straub H., Wenk M., et al. Adenosine A1 but not A2a receptor agonist reduces hyperalgesia caused by a surgical incision in rats: A pertussis toxin-sensitive G protein-dependent process. Anesthesiology 2007, 107(5):797-806.
190. Zavialov A.V., Engstrom A. Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity. The Biochemical Journal 2005, 391(Pt 1):51-57.
191. Zimmermann H. 5'-nucleotidase: Molecular structure and functional aspects. The Biochemical Journal 1992, 285:345-365.
192. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedeberg's Archives of Pharmacology 2000, 362(4-5):299-309.
193. Zimmermann H. Ectonucleotidases: Some recent developments and note on nomenclature. Drug Development Research 2001, 52:44-56.
194. Zimmermann H. Prostatic acid phosphatase, a neglected ectonucleotidase. Purinergic Signalling 2009, 5(3):273-275.
195. Zimmermann H., Braun N. Extracellular metabolism of nucleotides in the nervous system. Journal of Autonomic Pharmacology 1996, 16(6):397-400.
196. Zylka M.J., Sowa N.A., Taylor-Blake B., et al. Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine. Neuron 2008, 60(1):111-122.